These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15104931)

  • 1. [Simplification of the antiretroviral regimens. A need to guarantee the long-term control of HIV infection].
    Barreiro García P; Soriano Vázquez V
    Rev Clin Esp; 2004 Apr; 204(4):212-4. PubMed ID: 15104931
    [No Abstract]   [Full Text] [Related]  

  • 2. New antiretroviral drugs and approaches to HIV treatment.
    Paredes R; Clotet B
    AIDS; 2003; 17 Suppl 4():S85-96. PubMed ID: 15080184
    [No Abstract]   [Full Text] [Related]  

  • 3. Differences in antiretroviral regimens do not impact safety or level of latency reversal in persons receiving romidepsin.
    Jørgensen S; Leth S; Sommerfelt M; Østergaard L; Tolstrup M; Søgaard OS
    AIDS; 2018 Jul; 32(12):1729-1731. PubMed ID: 30001247
    [No Abstract]   [Full Text] [Related]  

  • 4. Induction-maintenance antiretroviral strategies to reduce long-term toxicity.
    Kelly M
    J HIV Ther; 2003 Feb; 8(1):11-4. PubMed ID: 12840709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beginning antiretroviral therapy for patients with HIV.
    Johnson JA; Sax PE
    Infect Dis Clin North Am; 2014 Sep; 28(3):421-38. PubMed ID: 25151564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preconception antiretroviral therapy and birth defects: what is needed?
    Bulterys M; Berry RJ; Watts DH
    AIDS; 2014 Nov; 28(18):2777-80. PubMed ID: 25493603
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiretroviral therapy: treatment-experienced individuals.
    Calvo KR; Daar ES
    Infect Dis Clin North Am; 2014 Sep; 28(3):439-56. PubMed ID: 25151565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key Principles of Antiretroviral Pharmacology.
    Dionne B
    Infect Dis Clin North Am; 2019 Sep; 33(3):787-805. PubMed ID: 31395145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comment on "Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid".
    Calcagno A; D'Avolio A; Di Perri G; Bonora S
    J Acquir Immune Defic Syndr; 2013 Apr; 62(4):e118-9. PubMed ID: 24135736
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to Calcagno comment on "Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid".
    Cusini A; Ledergerber B; Widmer N; Günthard HF
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):e14-5. PubMed ID: 24047974
    [No Abstract]   [Full Text] [Related]  

  • 11. The long-term consequences of antiretroviral therapy.
    Smith D
    J HIV Ther; 2006 Jun; 11(2):24-5. PubMed ID: 16981592
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of long-term antiretroviral therapy interruption and resumption on viral reservoir in HIV-1 infected patients.
    Montserrat M; Plana M; Guardo AC; Andrés C; Climent N; Gallart T; Leal L; Gatell JM; Sánchez-Palomino S; García F
    AIDS; 2017 Aug; 31(13):1895-1897. PubMed ID: 28590333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opinions of a small sample of pharmacists about pharmacy setting and patient adherence to antiretroviral therapy.
    Kibicho J; Owczarzak J; Pinkerton SD
    J Manag Care Pharm; 2012; 18(6):446-52. PubMed ID: 22839685
    [No Abstract]   [Full Text] [Related]  

  • 14. Once-daily antiretroviral therapy in a cohort of HIV-infected children and adolescents.
    Jiménez-Montero B; Beceiro J; de José-Gómez MI; González-Tomé MI; Gurbindo-Gutierrez D; Martínez-Pérez J; Mellado-Peña MJ; Navarro-Gómez ML; Roa-Francia MA; Rojo-Conejo P; Saavedra-Lozano J; Jiménez de Ory S; Ramos-Amador JT;
    Pediatr Infect Dis J; 2014 Oct; 33(10):1052-4. PubMed ID: 24747153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiviral treatment regimens].
    Esser S
    Hautarzt; 2006 Nov; 57(11):961-2, 964-8. PubMed ID: 17053925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008.
    Gazzard BG; Anderson J; Babiker A; Boffito M; Brook G; Brough G; Churchill D; Cromarty B; Das S; Fisher M; Freedman A; Geretti AM; Johnson M; Khoo S; Leen C; Nair D; Peters B; Phillips A; Pillay D; Pozniak A; Walsh J; Wilkins E; Williams I; Williams M; Youle M;
    HIV Med; 2008 Oct; 9(8):563-608. PubMed ID: 18826546
    [No Abstract]   [Full Text] [Related]  

  • 17. [Once-a-day highly active antiretroviral therapy. Present or future?].
    Pulido F; Hernando A
    Med Clin (Barc); 2003 Sep; 121(8):304-9. PubMed ID: 14499087
    [No Abstract]   [Full Text] [Related]  

  • 18. Simplification of antiretroviral therapy with etravirine.
    Martínez E; Nelson M
    AIDS Rev; 2010; 12(1):52-9. PubMed ID: 20216910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between atazanavir plasma levels and renal function in HIV-positive individuals on antiretroviral therapy with undetectable viral load.
    Luz AJ; Poeta J; Linden R; Antunes MV; Caminha LI; Callegari-Jacques SM; Sprinz E
    Int J Antimicrob Agents; 2013 May; 41(5):497-8. PubMed ID: 23453620
    [No Abstract]   [Full Text] [Related]  

  • 20. Individualized antiretroviral therapeutic approaches: less can be more.
    Katlama C; Ghosn J; Murphy RL
    AIDS; 2017 May; 31(8):1065-1071. PubMed ID: 28358730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.